EE496 Cost of Anti-CD38 Monoclonal Antibodies in Combination With Carfilzomib and Dexamethasone for Relapsed Refractory Multiple Myeloma
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2260
https://www.valueinhealthjournal.com/article/S1098-3015(24)02474-4/fulltext
Title :
EE496 Cost of Anti-CD38 Monoclonal Antibodies in Combination With Carfilzomib and Dexamethasone for Relapsed Refractory Multiple Myeloma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02474-4&doi=10.1016/j.jval.2024.03.2260
First page :
Section Title :
Open access? :
No
Section Order :
10255